Literature DB >> 3493839

Cytogenetic aspects of B-cell chronic lymphocytic leukemia: their correlation with clinical stage and different polyclonal mitogens.

G L Castoldi, F Lanza, A Cuneo.   

Abstract

Blood lymphocytes from 23 patients with B-cell chronic lymphocytic leukemia were stimulated with different mitogens (lipopolysaccharide from E coli, phorbol myristate acetate ester, Staphylococcus aureus, and phytohemagglutinin M form). Functional properties of stimulated cells (blastic transformation, mitotic index, cIg production, Ig secretion, and acid phosphatase positivity) were evaluated and correlated with the stage of disease and chromosomal findings. Early stages of the disease are characterized by a relatively homogeneous response to polyclonal B-cell and activators and by a restricted number of chromosomal aberrations. Advanced stages show a more heterogeneous pattern of response and a higher incidence of abnormal karyotypes suggesting an involvement of various subclonal lines.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3493839     DOI: 10.1016/0165-4608(87)90135-x

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens.

Authors:  Philip A Thompson; Susan M O'Brien; William G Wierda; Alessandra Ferrajoli; Francesco Stingo; Susan C Smith; Jan A Burger; Zeev Estrov; Nitin Jain; Hagop M Kantarjian; Michael J Keating
Journal:  Cancer       Date:  2015-07-20       Impact factor: 6.860

2.  Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia.

Authors:  Philip A Thompson; Constantine S Tam; Susan M O'Brien; William G Wierda; Francesco Stingo; William Plunkett; Susan C Smith; Hagop M Kantarjian; Emil J Freireich; Michael J Keating
Journal:  Blood       Date:  2015-10-22       Impact factor: 22.113

3.  Employment of oligodeoxynucleotide plus interleukin-2 improves cytogenetic analysis in splenic marginal zone lymphoma.

Authors:  Antonella Bardi; Francesco Cavazzini; Gian Matteo Rigolin; Elisa Tammiso; Eleonora Volta; Elisa Pezzolo; Luca Formigaro; Olga Sofritti; Giulia Daghia; Cristina Ambrosio; Lara Rizzotto; Awad E Abass; Fiorella D'Auria; Pellegrino Musto; Antonio Cuneo
Journal:  J Biomed Biotechnol       Date:  2011-05-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.